中国低风险甲状腺乳头状癌患者选择主动监测的障碍与促进因素:一项审视患者视角的定性研究
研究于2021年7月至11月目的性招募39例中国低风险甲状腺乳头状癌患者进行半结构化访谈,其中24例拒绝、15例选择主动监测。采用归纳内容分析提炼主题,将障碍与促进因素归类为患者相关、疾病相关和外部因素。结论认为患者对主动监测的接受度受多种因素影响,需将主动监测呈现为循证且优化的动态管理策略以提升公众接受度,临床医生应关注患者选择主动监测时的心理困扰并给予更多支持性干预。
要点
- 障碍与促进因素分为患者相关、疾病相关和外部因素三类。
- 患者相关因素包括知识、态度和情绪。
- 外部因素包括手术残留影响、主动监测方案和医生推荐。
核心结论
- 患者对主动监测作为管理方式的接受度复杂且受多种因素影响,需通过将主动监测呈现为循证且优化的动态管理策略来提升公众接受度。
- 临床医生必须处理患者选择主动监测时的心理困扰,患者需要更多关注和支持性干预。
研究设计与样本
- 定性研究,于2021年7月至11月目的性招募39例确诊低风险甲状腺乳头状癌患者进行半结构化访谈,其中24例拒绝、15例选择主动监测。
- 采用归纳内容分析提炼主题,并通过审计轨迹、成员核查和主题讨论确保严谨性。
主要发现
- 障碍与促进因素被归类为患者相关、疾病相关和外部因素。
- 患者相关因素包括患者的知识、态度和情绪。
- 疾病相关因素包括对患癌的反应、持续患病状态和感知的甲状腺价值。
- 外部因素包括手术的残留影响、主动监测方案和医生的推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Internationally, several clinical practice guidelines recommend active surveillance as a nonsurgical management strategy for select patients with low-risk papillary thyroid carcinoma. However, patient's decision making when choosing active surveillance as a management approach is not well understood. Thus, our aim was to examine the barriers and facilitators to selecting active surveillance among patients with low-risk papillary thyroid carcinoma in China. Methods: Thirty-nine participants diagnosed with low-risk papillary thyroid carcinoma were purposively recruited between July and November 2021 for semistructured interviews; 24 of whom rejected and 15 patients chose "active surveillance" as a management approach in our sample. Inductive content analysis illustrated emerging themes. Audit trails, member checks, and thematic discussions were used to assert rigor. Results: Barriers and facilitators were classified as patient-related, disease-related, and external factors. Patient-related factors included patient's knowledge, attitudes, and emotions. Disease-related factors included the response to having cancer, the constant state of being diseased, and perceived value of the thyroid gland. External factors included the residual effects of surgery, the active surveillance protocol, and physicians' recommendations. Conclusions: Patient's acceptability of the active surveillance as a management approach are complex with many influencing factors. The public acceptance of active surveillance as a disease management approach needs to be improved, through the presentation of active surveillance as an evidence-based and optimized dynamic management strategy. Clinicians must address their patients' psychological struggles when patients choose active surveillance and patients require more attention and supportive intervention.
引用
- Zhu P, Zhang Q, Wu Q, et al. Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives. Thyroid. 2023. PMID: 36719782. doi:10.1089/thy.2022.0347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。